Share:
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) Bionano Genomics, Inc. (NASDAQ:BNGO) announced today that company management will present virtually at the Oppenheimer MedTech, Tools & Diagnostics Summit being held on May 26, 2021.
The presentation will be available to view on the Events page in the Investors section of Bionano s website and at Oppenheimer MedTech, Tools, & Diagnostics Summit (wsw.com) on May 26, 2021 at 8am ET. The webcast of the event will be archived on Bionano s website for 30 days following the event.
About Bionano Genomics
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation
Bionano Genomics Reports First Quarter 2021 Financial Results and Highlights Recent Business Progress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Bionano Genomics Reports First Quarter 2021 Financial Results and Highlights Recent Business Progress
May 13, 2021 16:01 ET | Source: Bionano Genomics Bionano Genomics San Diego, California, UNITED STATES
179% year-over-year revenue increase driven by record sales of consumables and growth in the Saphyr installed base
All 2021 milestones on track
Strong balance sheet with $362 million cash as of March 31, 2021
Conference call today, Thursday, May 13, at 4:30 pm ET
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE)
Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the first quarter ended March 31, 2021 and highlighted recent corporate updates.
“2021 is off to a solid start for Bionano. In the first quarter, we sold a record number of flow cells, analyzed a record number of samples in our service lab, drove broad adoption of Saphyr instruments and ramped up the installation of Sa
Georgia Esoteric and Molecular Laboratory at Augusta University Now Offers Diagnostic Service for Constitutional Genetic Disorders based on Optical Genome Mapping with Bionano’s Saphyr System
May 03, 2021 08:00 ET | Source: Bionano Genomics Bionano Genomics San Diego, California, UNITED STATES
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that the Georgia Esoteric and Molecular (GEM) Laboratory at the Medical College of Georgia (MCG) at Augusta University is now offering diagnostic services for constitutional genetic disorders through a laboratory-developed test (LDT) based on optical genome mapping (OGM) with the Saphyr® System. The LDT developed by Dr. Ravindra Kolhe and his team is designed for pediatric patients suspected to have a neurodevelopmental genetic disorder. Dr. Kolhe is developing additional OGM-based LDTs for prenatal genetic disorders and other indications.